Drug Trial Radar · NCT01214421
Tolvaptan Extension Study in Participants With ADPKD
Last checked: Nov 20, 2026Latest source record: Oct 25, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,083
Actual
Start
May 26, 2010
Primary completion
Feb 29, 2016
Study completion Feb 29, 2016
Sponsor
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.Otsuka
- Sponsor type
- Industry
- First posted
- Oct 5, 2010
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To demonstrate whether tolvaptan modifies ADPKD progression as measured by changes from Baseline (from Study 156-04-251) in total kidney volume (TKV) and renal function.
Conditions
- Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Interventions
TolvaptanDrug
Tablets of 15 or 30 mg
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change From the Baseline in Total Kidney Volume (TKV) for Study 156-04-251 Participants Enrolled in This Study (156-08-271)Time frame: Study Baseline (Prior to Day 1 in Study 156-04-251) to Month 24 in this study (Study 156-08-271)
Locations
97 sites in 13 countries. Site status is shown where the registry gives one.
Otsuka Investigational Site
Mobile, Alabama
Otsuka Investigational Site
Peoria, Arizona
Otsuka Investigational Site
Tempe, Arizona
Otsuka Investigational Site
Los Angeles, California
Otsuka Investigational Site
Palo Alto, California
Otsuka Investigational Site
San Diego, California
Otsuka Investigational Site
Aurora, Colorado
Otsuka Investigational Site
New Haven, Connecticut
Otsuka Investigational Site
Jacksonville, Florida
Otsuka Investigational Site
Port Charlotte, Florida
Otsuka Investigational Site
Atlanta, Georgia
Otsuka Investigational Site
Augusta, Georgia
Otsuka Investigational Site
Chicago, Illinois
Otsuka Investigational Site
Kansas City, Kansas
Otsuka Investigational Site
Baton Rouge, Louisiana
Otsuka Investigational Site
Baltimore, Maryland
Otsuka Investigational Site
Rockville, Maryland
Otsuka Investigational Site
Boston, Massachusetts
Otsuka Investigational Site
Detroit, Michigan
Otsuka Investigational Site
Minneapolis, Minnesota
Otsuka Investigational Site
Rochester, Minnesota
Otsuka Investigational Site
Voorhees Township, New Jersey
Otsuka Investigational Site
Buffalo, New York
Otsuka Investigational Site
Hawthorne, New York
Otsuka Investigational Site
New York, New York
Otsuka Investigational Site
New York, New York
Otsuka Investigational Site
Chapel Hill, North Carolina
Otsuka Investigational Site
Cincinnati, Ohio
Otsuka Investigational Site
Cleveland, Ohio
Otsuka Investigational Site
Portland, Oregon
Otsuka Investigational Site
Bethlehem, Pennsylvania
Otsuka Investigational Site
Philadelphia, Pennsylvania
Otsuka Investigational Site
Anderson, South Carolina
Otsuka Investigational Site
Nashville, Tennessee
Otsuka Investigational Site
Nashville, Tennessee
Otsuka Investigational Site
Arlington, Texas
Otsuka Investigational Site
McAllen, Texas
Otsuka Investigational Site
Charlottesville, Virginia
Otsuka Investigational Site
Buenos Aires, Argentina
Otsuka Investigational Site
Córdoba, Argentina
Showing 40 of 97 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.